  |
 |
 |
While consulting for scientists at the Stanford Medical School, MedStars developed a paradigm-shifting business model to commercialize a new robotic DNA synthesis technology. Dr. Molinari became the founding CEO of Protogene, which then grew into the world's largest supplier of custom DNA within its first 2 years, and generated over $10 million in liquid returns to its founders in that time. |
 |
||||||
|
 |
||||||||
